Literature DB >> 11393777

Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.

T Kon1, T J Cho, T Aizawa, M Yamazaki, N Nooh, D Graves, L C Gerstenfeld, T A Einhorn.   

Abstract

Fracture healing is a unique biological process regulated by a complex array of signaling molecules and proinflammatory cytokines. Recent evidence for the role of tumor necrosis family members in the coupling of cellular functions during skeletal homeostasis suggests that they also may be involved in the regulation of skeletal repair. The expression of a number of cytokines and receptors that are of functional importance to bone remodeling (osteoprotegerin [OPG], macrophage colony-stimulating factor [M-CSF], and osteoprotegerin ligand [receptor activator of NF-kappaB ligand (RANKL)]), as well as inflammation (tumor necrosis factor alpha [TNF-alpha] and its receptors, and interleukin-1alpha [IL-1alpha] and -beta and their receptors) were analyzed over a 28-day period after the generation of simple transverse fractures in mouse tibias. OPG was expressed constitutively in unfractured bones and elevated levels of expression were detected throughout the repair process. It showed two distinct peaks of expression: the first occurring within 24 h after fracture and the second at the time of peak cartilage formation on day 7. In contrast, the expression of RANKL was nearly undetectable in unfractured bones but strongly induced throughout the period of fracture healing. The peak in expression of RANKL did not correlate with that of OPG, because maximal levels of expression were seen on day 3 and day 14, when OPG levels were decreasing. M-CSF expression followed the temporal profile of RANKL but was expressed at relatively high basal levels in unfractured bones. TNF-alpha, lymphotoxin-beta (LT-beta), IL-1alpha, and IL-1beta showed peaks in expression within the first 24 h after fracture, depressed levels during the period of cartilage formation, and increased levels of expression on day 21 and day 28 when bone remodeling was initiated. Both TNF-alpha receptors (p55 and p75) and the IL-1RII receptor showed identical patterns of expression to their ligands, while the IL-1R1 was expressed only during the initial period of inflammation on day 1 and day 3 postfracture. Both TNF-alpha and IL-1alpha expression were localized primarily in macrophages and inflammatory cells during the early periods of inflammation and seen in mesenchymal and osteoblastic cells later during healing. TNF-alpha expression also was detected at very high levels in hypertrophic chondrocytes. These data imply that the expression profiles for OPG, RANKL, and M-CSF are tightly coupled during fracture healing and involved in the regulation of both endochondral resorption and bone remodeling. TNF-alpha and IL-1 are expressed at both very early and late phases in the repair process, which suggests that these cytokines are important in the initiation of the repair process and play important functional roles in intramembraneous bone formation and trabecular bone remodeling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11393777     DOI: 10.1359/jbmr.2001.16.6.1004

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  154 in total

1.  A2B adenosine receptor promotes mesenchymal stem cell differentiation to osteoblasts and bone formation in vivo.

Authors:  Shannon H Carroll; Nathan A Wigner; Nitin Kulkarni; Hillary Johnston-Cox; Louis C Gerstenfeld; Katya Ravid
Journal:  J Biol Chem       Date:  2012-03-08       Impact factor: 5.157

2.  Student Award for Outstanding Research Winner in the Ph.D. Category for the 9th World Biomaterials Congress, Chengdu, China, June 1-5, 2012: The interplay of bone-like extracellular matrix and TNF-α signaling on in vitro osteogenic differentiation of mesenchymal stem cells.

Authors:  Paschalia M Mountziaris; Stephanie N Tzouanas; Antonios G Mikos
Journal:  J Biomed Mater Res A       Date:  2012-02-18       Impact factor: 4.396

Review 3.  Skeletal Blood Flow in Bone Repair and Maintenance.

Authors:  Ryan E Tomlinson; Matthew J Silva
Journal:  Bone Res       Date:  2013-12-31       Impact factor: 13.567

4.  A pilot study investigating the histology and growth factor content of human non-union tissue.

Authors:  Philipp Schwabe; Paul Simon; Zienab Kronbach; Gerhard Schmidmaier; Britt Wildemann
Journal:  Int Orthop       Date:  2014-08-27       Impact factor: 3.075

5.  Mouse models of bone healing: fracture, marrow ablation, and distraction osteogenesis.

Authors:  Kyle Lybrand; Beth Bragdon; Louis Gerstenfeld
Journal:  Curr Protoc Mouse Biol       Date:  2015-03-02

Review 6.  Overview of biological mechanisms and applications of three murine models of bone repair: closed fracture with intramedullary fixation, distraction osteogenesis, and marrow ablation by reaming.

Authors:  Beth Bragdon; Kyle Lybrand; Louis Gerstenfeld
Journal:  Curr Protoc Mouse Biol       Date:  2015-03-02

7.  Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy.

Authors:  Hiromu Ito; Mette Koefoed; Prarop Tiyapatanaputi; Kirill Gromov; J Jeffrey Goater; Jonathan Carmouche; Xinping Zhang; Paul T Rubery; Joseph Rabinowitz; R Jude Samulski; Takashi Nakamura; Kjeld Soballe; Regis J O'Keefe; Brendan F Boyce; Edward M Schwarz
Journal:  Nat Med       Date:  2005-02-13       Impact factor: 53.440

Review 8.  Theories concerning the pathogenesis of the acute charcot foot suggest future therapy.

Authors:  William J Jeffcoate
Journal:  Curr Diab Rep       Date:  2005-12       Impact factor: 4.810

9.  Lineage-Specific Wnt Reporter Elucidates Mesenchymal Wnt Signaling during Bone Repair.

Authors:  Leslie Chang; Lei Zhang; Jiajia Xu; Carolyn A Meyers; Zhu Li; Noah Yan; Erin Zou; Aaron W James
Journal:  Am J Pathol       Date:  2018-07-20       Impact factor: 4.307

Review 10.  Recent advances in bone regeneration using adult stem cells.

Authors:  Hadar Zigdon-Giladi; Utai Rudich; Gal Michaeli Geller; Ayelet Evron
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.